Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use OXYMORPHONE hydrochloride Extended-Release Tablets safely and effectively. See full prescribing information for OXYMORPHONE hydrochloride Extended-Release Tablets. OXYMORPHONE hydrochloride Extended-Release Tablets, for oral use, CII Initial U.S. Approval: 1959
Medication labelWhy this: Advisory · dailymed-prescription
Oxymorphone hydrochloride extended-release tablets are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Limitations of Usage Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations, reserve oxymorphone hydrochloride extended-release tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. Oxymorphone hydrochloride extended-release tablets are not indicated as an as-needed (prn) analgesic.
- generic_name
- oxymorphone hydrochloride
- product_names
- Oxymorphone hydrochloride
- ndc
- 63304-218, 63304-219, 63304-220, 63304-221, 63304-222, 63304-223, 63304-224, 63304-218-30, 63304-218-05, 63304-219-30, 63304-219-05, 63304-220-30, 63304-220-05, 63304-221-30, 63304-221-05, 63304-222-30, 63304-222-05, 63304-223-30, 63304-223-05, 63304-224-30, 63304-224-05
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en